Prognostic value of blood neutrophil-to-lymphocyte ratio (NLR)in advanced pancreatic cancer patients treated with Nab-paclitaxel and Gemcitabine: our experience

Authors :: Jole Ventriglia
A. Diana
Giuseppe Tirino
Maria Maddalena Laterza
Alessio Fabozzi
Michele Orditura
Angelica Petrillo
Fortunato Ciardiello
F. De Vita
G. Giordano
B. Savastano
Source :: Annals of Oncology. 26:vi101
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Lymphocyte
Hematology
Blood neutrophil
medicine.disease
Gemcitabine
medicine.anatomical_structure
Internal medicine
Pancreatic cancer
medicine
business
Value (mathematics)
medicine.drug
Nab-paclitaxel

Full Text Access

Tools